hyaluronoglucosaminidase has been researched along with Cardiovascular Stroke in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 88 (93.62) | 18.7374 |
1990's | 4 (4.26) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (1.06) | 24.3611 |
2020's | 1 (1.06) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Ge, Z; Lu, G; Ma, Y; Pu, J; Xie, Y; Yuan, A | 1 |
Binder, RK; Crea, F; Lüscher, TF; Widimsky, P | 1 |
CARBALLO, R; MARTINS DE OLIVEIRA, J; ZIMMERMAN, HA | 1 |
BAILAO, N; BOCCALANDRO, I; EBAID, M; PILEGGI, F; TRANCHESI, J | 1 |
FOELDI, M; SOLTI, F | 1 |
ARRUDA, RM; BARBATO, E; CARAMELLI, Z; EBAID, M; PILLEGI, F; TRANCHESI, J | 1 |
ANACLETO, JC; BRAILE, DM; CARAMELLI, Z; DECOURT, LV; EBAID, M; MERCURIONETO, S; ROLLEMBERG, MI | 1 |
BASZKO, A; PELKA, W; TKACZEWSKI, W | 1 |
LEVY, MN; MARTINS DE OLIVEIRA, J | 1 |
Jezková, Z; Pokorný, J | 1 |
Adgey, AA; Geddes, JS; Pantridge, JF | 1 |
Kjekshus, JK | 1 |
Opie, LH | 1 |
da Luz, PL; de Barros, LF; Leite, JJ; Pileggi, F | 1 |
Ruda, MIa | 1 |
Braunwald, E; Muller, JE; Rude, RE | 1 |
Coltart, DJ; Croft, DN; Robinson, PS; Saltissi, S; Webb-Peploe, MM | 1 |
Cadigan, PJ; De Giovanni, J; Flint, EJ; Lamb, P; Pentecost, BL | 1 |
Campbell, RW; Henderson, A; Julian, DG | 1 |
Oliver, MF | 1 |
Mitchell, JR | 1 |
Braunwald, E; Muller, JE | 1 |
Sleight, P; Yusuf, S | 1 |
Sleight, P | 1 |
Boland, J; Legrand, V | 1 |
Caruso, JW; Corbally, F; Daly, SJ; Fitzgerald, DL; Hurwitz, H; Kauffman, JM; Lowney, JD; Papa, LA; Schiff, S | 1 |
Nilsson, JE; Säwe, U; Sjögren, C | 1 |
Akers, M; Beecher, P; Helminger, K; Moses, B; Mullin, SM; Rigby, PA; Taplin, NE; Warwick, S; Werner, W; Wettach, R | 1 |
Pentecost, BL | 2 |
Hirzel, HO | 1 |
Afonskaia, NI; Avaliani, AG; Ruda, MIa; Vikhert, AM; Zysko, AP | 1 |
Cairns, JA; Holder, DA; Missirlis, E; Tanser, P | 1 |
Chaung, LY; Muller, JE; O'Hara, D; Smith, TW; Wolf, RA | 1 |
Cheung, WM; Faria, DB; Iwasaki, T; Maroko, PR; Ribeiro, LG | 1 |
Salkie, ML | 2 |
Abrams, HL; Adams, DF; Hollenberg, NK; Szlavy, L | 1 |
Braunwald, E; Kloner, RA; Maroko, PR | 2 |
LaPenna, WF; McNamara, JJ; Premaratne, S; Watanabe, BI | 1 |
Kones, RJ; Phillips, JH | 1 |
Opolski, G; Zochowski, RJ | 1 |
Danner, SA | 1 |
Belz, GG; Erbel, R | 1 |
Zilcher, H | 1 |
Bobba, P; Ray, M; Salerno, JA; Tavazzi, L | 1 |
Bobba, P; Chimienti, M; Medici, A; Piccinini, M; Ray, M; Salerno, JA; Tavazzi, L | 1 |
Braunwald, E; Maroko, PR | 6 |
Braunwald, E; Hillis, LD | 1 |
Davis, MA; Hillis, LD; Louie, EK; Maroko, PR; Ribeiro, LG | 1 |
Afonskaia, NI; Cherpachenko, NM; Zhdanov, VS | 1 |
Afonskaia, NI; Lazutin, VK; Maller, D; Nikolaeva, LF; Saprygin, DB | 1 |
Braunwald, E; Davis, MA; Hillis, LD; Louie, EK; Maroko, PR; Riberio, LG | 1 |
Barletta, MA; Lau Cam, C; Lynch, VD; Staab, R | 1 |
Bleifeld, W | 1 |
Askenazi, J; Bobba, P; Braunwald, E; Carpentier, J; Chazov, EI; Chiariello, M; Distante, A; Heyndrickx, GR; Hillis, LD; Libby, P; Maroko, PR; Muller, JE; Raabe, DS; Radvany, P; Ray, M; Reshetnaya, NI; Salerno, J; Tavazzi, L | 1 |
Chazov, EI; Nikolaeva, LF; Ruda, MIa | 1 |
Braunwald, E; Fishbein, MC; Hillis, LD; Maroko, PR | 1 |
Rutenberg, HL | 1 |
Afonskaia, NI; Nikolaeva, LF; Sharov, VG | 1 |
Capone, RJ; Mastrofrancesco, PA; Most, AS | 1 |
Braunwald, E; Fishbein, MC; Maclean, D; Maroko, PR | 1 |
Askenazi, J; Braunwald, E; Fishbein, MC; Hillis, LD; Maroko, PR; Muller, JE; Radvany, P | 1 |
Braunwald, E; Davidson, DM; Hagan, AD; Libby, P; Maroko, PR | 1 |
Machura, B; Piestrak, J; Schmidt, M | 1 |
Garnic, JD; Hollenberg, NK; Repa, I | 1 |
Gerdin, B; Hällgren, R; Martinussen, HJ; Waldenström, A | 1 |
Fukuda, S; Koga, M; Taira, A; Takenada, K; Uehara, K | 1 |
Lu, X; Tan, XL; Zhang, WN | 1 |
Mukherjee, D | 1 |
Col, JJ | 1 |
Yusuf, S | 1 |
Sanders, AB | 1 |
Cadigan, PJ; Hall, RJ; Julian, DG; Pentecost, BL; Petri, MC; Simpson, JM; Smith, RH | 1 |
Braunwald, E; Croft, C; Gold, HK; Hartwell, TD; Jaffe, AS; Muller, JE; Mullin, SM; Parker, C; Passamani, ER; Roberts, R | 1 |
Lu, X | 1 |
Alpers, P; Gottwik, M; Hofmann, M; Kirchner, PK; Schaper, J | 1 |
Slezák, J | 1 |
Antonetti, F; Borrelli, F; Caprino, L; Martelli, F | 1 |
de Courten, A; Hollenberg, NK; Koster, K; Szlavy, L | 1 |
Dodgson, KS; Earnshaw, JS; Gacesa, P; Olavesen, AH; Peh, KH | 1 |
Gwilt, DJ; Lewis, PW; Nattrass, M; Pentecost, BL; Petri, M | 1 |
Stavitskiĭ, IuL | 1 |
Smith, ER | 1 |
Braunwald, E; Libby, P; Maroko, PR | 1 |
Bloor, CM; Braunwald, E; Libby, P; Maroko, PR; Sobel, BE | 1 |
19 review(s) available for hyaluronoglucosaminidase and Cardiovascular Stroke
Article | Year |
---|---|
The year in cardiology 2018: acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adaptive Immunity; Anticoagulants; Biomarkers; Carrier Proteins; Cell Adhesion Molecules; Diagnostic Techniques, Cardiovascular; Dual Anti-Platelet Therapy; Early Diagnosis; Gene Expression; GPI-Linked Proteins; Heart; Humans; Hyaluronan Receptors; Hyaluronoglucosaminidase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Immunity, Innate; Magnetic Resonance Imaging, Cine; Myocardial Infarction; Oxygen Inhalation Therapy; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Risk Assessment; Rupture; Sex Factors; Stents; Takotsubo Cardiomyopathy; Troponin; Vascular Remodeling | 2019 |
Prevention of cardiogenic shock.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Creatine Kinase; Echocardiography; Electrocardiography; Extracellular Space; Heart Rate; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nifedipine; Osmotic Pressure; Oxygen Consumption; Oxygen Inhalation Therapy; Radionuclide Imaging; Shock, Cardiogenic; Verapamil | 1980 |
Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Glucose; Heart Rate; Heparin; Humans; Hyaluronoglucosaminidase; Hyperglycemia; Insulin; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Potassium; Propranolol; Time Factors | 1980 |
[Protection for the ischemic myocardium: a transition between the experimental laboratory and medical practice].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Animals; Calcium; Coronary Disease; Humans; Hyaluronoglucosaminidase; Insulin; Intra-Aortic Balloon Pumping; Myocardial Infarction; Myocardial Revascularization; Perfusion; Potassium; Vasodilator Agents | 1980 |
"But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Care Units; Female; Fibrinolytic Agents; Heart Function Tests; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Risk; Time Factors; Vasodilator Agents | 1982 |
Can infarct size be limited in patients with acute myocardial infarction?
Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Dogs; Fibrinolytic Agents; Glucose; Humans; Hyaluronoglucosaminidase; Hypertension; Insulin; Intra-Aortic Balloon Pumping; Myocardial Infarction; Necrosis; Nitroglycerin; Oxygen; Oxygen Consumption; Potassium; Vasodilator Agents | 1983 |
[Prospects for the limitation of the size of acute myocardial infarction].
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Anticoagulants; Coronary Artery Bypass; Coronary Vasospasm; Coronary Vessels; Creatine Kinase; Fibrinolytic Agents; Fluid Therapy; Fluorocarbons; Humans; Hyaluronoglucosaminidase; Intra-Aortic Balloon Pumping; Isoenzymes; L-Lactate Dehydrogenase; Myocardial Infarction; Nitrates; Oxygen Consumption | 1983 |
Reduction of myocardial infarct size by early intervention.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Animals; Dogs; Fibrinolytic Agents; Humans; Hyaluronoglucosaminidase; Infusions, Parenteral; Intra-Aortic Balloon Pumping; Myocardial Infarction; Oxygen; Vasodilator Agents | 1977 |
[Recent aspects on basic drug therapy of acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Allopurinol; Analgesics; Anticoagulants; Aprotinin; Cardiac Glycosides; Elapid Venoms; Glucocorticoids; Glucose; Humans; Hyaluronoglucosaminidase; Hypnotics and Sedatives; Injections, Intravenous; Insulin; Mannitol; Myocardial Infarction; Nicotinic Acids; Nitrites; Nitroglycerin; Nitroprusside; Potassium; Streptokinase | 1977 |
[Hemodynamic and therapeutic aspects of acute myocardial infarct. II. Pharmacological evaluations and guidelines for therapy].
Topics: Acute Disease; Digoxin; Diuretics; Heart; Hemodynamics; Humans; Hyaluronoglucosaminidase; Methylprednisolone; Myocardial Infarction; Propranolol; Vasodilator Agents | 1978 |
Limitation of infarct size.
Topics: Assisted Circulation; Coronary Disease; Coronary Vessels; Electrocardiography; Heart; Humans; Hyaluronoglucosaminidase; Mannitol; Myocardial Infarction; Myocardium; Oxygen Consumption; Wound Healing | 1978 |
Myocardial ischemia (third of three parts).
Topics: Acute Disease; Animals; Assisted Circulation; Coronary Disease; Disease Models, Animal; Dogs; Glucocorticoids; Hemodynamics; Humans; Hyaluronoglucosaminidase; Methods; Myocardial Contraction; Myocardial Infarction; Nitroglycerin; Oxygen Inhalation Therapy; Propranolol; Rats; Time Factors | 1977 |
Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
Topics: Anaerobiosis; Animals; Dogs; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Insulin; Isoproterenol; Methoxamine; Myocardial Infarction; Myocardium; Oxygen Consumption; Phenylephrine; Potassium; Propranolol | 1976 |
[Possibilities of preserving ischemic myocardium].
Topics: Acute Disease; Animals; Coronary Circulation; Coronary Disease; Dipyridamole; Fibrinolysis; Humans; Hyaluronoglucosaminidase; Myocardial Contraction; Myocardial Infarction; Nitroglycerin; Verapamil | 1976 |
Interventions that potentially limit myocardial infarct size: overview of clinical trials.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Clinical Trials as Topic; Ferricyanides; Fibrinolytic Agents; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Nitroprusside; Random Allocation; Risk; Streptokinase | 1987 |
Myocardial salvage: pharmacologic treatment.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Calcium Channel Blockers; Cardiovascular Agents; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitrates; Superoxide Dismutase | 1988 |
[The development of ischemic damage to the myocardium and a review of methods which decrease it].
Topics: Anti-Inflammatory Agents; Calcium Channel Blockers; Coronary Circulation; Glucose; Heart Arrest, Induced; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium; Oxygen Consumption; Shock, Cardiogenic; Vasodilator Agents | 1986 |
Acute myocardial infarction and muscle salvage: a potential role for pharmacological agents.
Topics: Adenosine; Adrenergic alpha-Agonists; Animals; Assisted Circulation; Collateral Circulation; Coronary Artery Bypass; Coronary Circulation; Digitalis Glycosides; Diuretics; Electric Stimulation; Glucocorticoids; Glucose; Humans; Hyaluronoglucosaminidase; Insulin; Ischemia; Myocardial Infarction; Myocardium; Necrosis; Nitroglycerin; Oxygen; Oxygen Consumption; Potassium; Propranolol; Ventricular Fibrillation | 1974 |
Reduction of infarct size following coronary occlusion.
Topics: Anaerobiosis; Animals; Assisted Circulation; Coronary Vessels; Creatine Kinase; Electrocardiography; Glucose; Glycolysis; Heart Ventricles; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Insulin; Ischemia; Isoproterenol; Myocardial Infarction; Myocardium; Necrosis; Oxygen Consumption; Perfusion; Potassium; Propranolol | 1974 |
17 trial(s) available for hyaluronoglucosaminidase and Cardiovascular Stroke
Article | Year |
---|---|
Effects of early administration of a highly purified hyaluronidase preparation (GL enzyme) on myocardial infarct size.
Topics: Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Heart; Hemodynamics; Humans; Hyaluronoglucosaminidase; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Random Allocation | 1982 |
Effect of GL enzyme (a highly purified form of hyaluronidase) on mortality after myocardial infarction.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Heart Failure; Humans; Hyaluronoglucosaminidase; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 1982 |
Effect of a highly purified hyaluronidase preparation (GL enzyme) on electrocardiographic changes in acute myocardial infarction.
Topics: Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Random Allocation | 1982 |
"But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Care Units; Female; Fibrinolytic Agents; Heart Function Tests; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Risk; Time Factors; Vasodilator Agents | 1982 |
The use of hyaluronidase in acute myocardial infarction.
Topics: Clinical Trials as Topic; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Random Allocation | 1983 |
An acute intervention trial: the research nurse coordinator's role.
Topics: Administrative Personnel; Clinical Trials as Topic; Electrocardiography; Follow-Up Studies; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nurse Administrators; Propranolol; Random Allocation; Research Design | 1984 |
Hyaluronidase in the management of myocardial infarction.
Topics: Clinical Trials as Topic; Humans; Hyaluronoglucosaminidase; Myocardial Infarction | 1982 |
[Results of trials of limiting the size of the focal lesion in myocardial infarct infarct by drugs].
Topics: Clinical Trials as Topic; Electrocardiography; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Time Factors; Verapamil | 1982 |
Preventing the second infarct.
Topics: Adult; Animals; Clinical Trials as Topic; Death, Sudden; Dogs; Electrocardiography; Exercise Therapy; Humans; Hyaluronoglucosaminidase; Middle Aged; Monitoring, Physiologic; Myocardial Infarction; Practolol; Recurrence; Smoking Prevention; Sulfinpyrazone | 1980 |
Intravenous hyaluronidase therapy for myocardial infarction in man: double-blind trial to assess infarct size limitation.
Topics: Adult; Aged; Creatine Kinase; Double-Blind Method; Electrocardiography; Female; Humans; Hyaluronoglucosaminidase; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis | 1982 |
Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Electrocardiography; Female; Humans; Hyaluronoglucosaminidase; Injections, Intradermal; Male; Middle Aged; Myocardial Infarction; Necrosis | 1977 |
Effects of hyaluronidase administration on myocardial ischemic injury in acute infarction. A preliminary study in 24 patients.
Topics: Acute Disease; Animals; Coronary Vessels; Dogs; Electrocardiography; Female; Humans; Hyaluronoglucosaminidase; Ischemia; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Rabbits | 1975 |
Hyaluronidase therapy for acute myocardial infarction: results of a randomized, blinded, multicenter trial. MILIS Study Group.
Topics: Animals; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Myocardial Infarction; Random Allocation | 1986 |
Myocardial salvage by medical therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Nitroprusside; Streptokinase | 1985 |
Interventions that potentially limit myocardial infarct size: overview of clinical trials.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Clinical Trials as Topic; Ferricyanides; Fibrinolytic Agents; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Nitroprusside; Random Allocation; Risk; Streptokinase | 1987 |
A controlled trial of GL enzyme in the treatment of acute myocardial infarction.
Topics: Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Myocardial Infarction; Random Allocation; Time Factors | 1988 |
Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS).
Topics: Clinical Trials as Topic; Coronary Disease; Creatine Kinase; Double-Blind Method; Humans; Hyaluronoglucosaminidase; Isoenzymes; Multicenter Studies as Topic; Myocardial Infarction; Myocardium; Propranolol; Random Allocation; Stroke Volume; Time Factors | 1988 |
60 other study(ies) available for hyaluronoglucosaminidase and Cardiovascular Stroke
Article | Year |
---|---|
BMP6 knockdown enhances cardiac fibrosis in a mouse myocardial infarction model by upregulating AP-1/CEMIP expression.
Topics: Animals; Bone Morphogenetic Protein 6; Collagen Type I; Disease Models, Animal; Heart; Hyaluronoglucosaminidase; Mice; Myocardial Infarction; Transcription Factor AP-1 | 2023 |
Intravenous injection of hyaluronidase in acute myocardial infarction: preliminary report of clinical and experimental observations.
Topics: Anterior Wall Myocardial Infarction; Cardiovascular Diseases; Humans; Hyaluronoglucosaminidase; Injections, Intravenous; Myocardial Infarction | 1959 |
[The use of hyaluronidase in recent myocardial infarct. Electrocardiographic study].
Topics: Electrocardiography; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium | 1960 |
[EFFECT OF HYASE ON THE LOW-VOLTAGE ECG].
Topics: Coronary Disease; Drug Therapy; Electrocardiography; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Myxedema; Pulmonary Emphysema | 1964 |
[EFFECT OF HIGH DOSES OF GLUCOCORTICOIDS AND HYALURONIDASE, ADMINISTERED BY INTRAVENOUS ROUTE, ON ELECTROCRADIOGRAPHIC CHANGES IN ACUTE MYOCARDIAL INFARCT. II. CLINICAL STUDY].
Topics: Biomedical Research; Electrocardiography; Geriatrics; Glucocorticoids; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Myocardial Infarction; Myocardium | 1965 |
[EFFECT OF HIGH DOSES OF GLUCOCORTCOIDS AND HYALURONIDASE, ADMINISTERED BY INTRAVENOUS ROUTE, ON ELECTROCARDIOGRAPHIC CHANGES IN ACUTE MYOCARDIAL INFARCT. I. EXPERIMENTAL STUDY].
Topics: Animals; Dogs; Electrocardiography; Hyaluronoglucosaminidase; Hydrocortisone; Myocardial Infarction; Myocardium; Research | 1965 |
[RHYTHM AND CONDUCTION DISORDERS IN ACUTE MYOCARDIAL INFARCTION TREATED WITH HYALURONIDASE].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Block; Heart Conduction System; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Toxicology | 1965 |
Effects of hyaluronidase upon the water content of ischemic myocardium.
Topics: Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium; Water | 1960 |
The appearance of a wide variety of antibodies in atherosclerosis.
Topics: Aged; Antibody Formation; Arteriosclerosis; Blood Vessels; Cholesterol; Female; Heparin; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Middle Aged; Myocardial Infarction; Myocardium; Phospholipids; Polysaccharides; Pyridoxine; Serologic Tests; Thromboangiitis Obliterans | 1967 |
[Treatment of acute myocardial infarction].
Topics: Acute Disease; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Humans; Hyaluronoglucosaminidase; Lidocaine; Myocardial Infarction; Oxygen; Steroids; Vasodilator Agents | 1980 |
[Restriction of the lesion focus in myocardial infarct].
Topics: Adrenergic beta-Antagonists; Heart; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Vasodilator Agents | 1981 |
Efforts to limit the size of myocardial infarcts.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Creatine Kinase; Electrocardiography; Fibrinolytic Agents; Glucose; Humans; Hyaluronoglucosaminidase; Insulin; Intra-Aortic Balloon Pumping; Isoenzymes; Myocardial Infarction; Nitroglycerin; Oxygen; Perfusion; Potassium; Vasodilator Agents | 1981 |
Effect of hyaluronidase (GL enzyme) on mortality after myocardial infarction.
Topics: Arrhythmias, Cardiac; Hyaluronoglucosaminidase; Myocardial Infarction; Time Factors | 1982 |
Limitation of myocardial infarct size. Present status.
Topics: Adrenergic beta-Antagonists; Electrocardiography; Glucose; Humans; Hyaluronoglucosaminidase; Insulin; Myocardial Infarction; Potassium; Streptokinase; Vasodilator Agents | 1983 |
Interventions during and after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Anticoagulants; Arrhythmias, Cardiac; Calcium Channel Blockers; Diet; Electrocardiography; Heart Rate; Humans; Hyaluronoglucosaminidase; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Streptokinase | 1983 |
The effects of a highly purified hyaluronidase preparation on experimental myocardial infarction in the rat.
Topics: Animals; Cattle; Drug Evaluation; Female; Hyaluronoglucosaminidase; L-Lactate Dehydrogenase; Myocardial Infarction; Rats; Rats, Inbred Strains | 1984 |
[Use of mannitol, hyaluronidase and glucose-insulin-potassium in the treatment of acute myocardial infarction (author's transl)].
Topics: Acute Disease; Coronary Circulation; Drug Therapy, Combination; Electrocardiography; Energy Metabolism; Glucose; Glucose Solution, Hypertonic; Humans; Hyaluronoglucosaminidase; Insulin; Mannitol; Myocardial Infarction; Potassium | 1981 |
The serum kinetics of bovine testicular hyaluronidase in dogs, rats and humans.
Topics: Animals; Dogs; Half-Life; Humans; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; Kinetics; Male; Methods; Myocardial Infarction; Rats; Species Specificity; Testis | 1982 |
Importance of the source of hyaluronidase preparations in determining protective effect on ischemic heart muscle in acute myocardial infarction.
Topics: Acute Disease; Animals; Autoradiography; Cattle; Coronary Disease; Dogs; Fungi; Hemodynamics; Hyaluronoglucosaminidase; Male; Myocardial Infarction; Necrosis; Testis | 1981 |
Glycosaminoglycan metabolism following acute myocardial infarction and the effects of intravenous hyaluronidase therapy.
Topics: Glycosaminoglycans; Heparin; Humans; Hyaluronoglucosaminidase; Myocardial Infarction | 1980 |
Cardiac lymph and lymphatics in normal and infarcted myocardium.
Topics: Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Coronary Angiography; Dogs; Electrocardiography; Female; Heart; Hyaluronoglucosaminidase; Lymph; Lymphatic System; Lymphography; Male; Myocardial Infarction; Myocardium | 1980 |
Analysis of the geometry of myocardial infarct size reduction with hyaluronidase.
Topics: Animals; Cicatrix; Dogs; Endocardium; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium; Time Factors | 1980 |
Effects of hyaluronidase on reducing myocardial infarct size in a baboon model of ischemia-reperfusion injury.
Topics: Animals; Disease Models, Animal; Female; Hemodynamics; Hyaluronoglucosaminidase; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Papio | 1995 |
Reduction in myocardial infarct size: prevention of heart cell death.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Assisted Circulation; Autolysis; Cardiac Output; Coronary Circulation; Energy Metabolism; Energy Transfer; Glucose; Humans; Hyaluronoglucosaminidase; Insulin; Myocardial Infarction; Myocardium; Necrosis; Oxygen Consumption; Perfusion; Potassium; Vasodilator Agents | 1976 |
[Possibilities of reducing of the area of myocardial infarction].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Cardiac Glycosides; Heart Failure; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Shock, Cardiogenic | 1977 |
[Measures to reduce infarct size (author's transl)].
Topics: Animals; Coronary Artery Bypass; Coronary Circulation; Energy Metabolism; Hemodynamics; Humans; Hyaluronoglucosaminidase; Infusions, Parenteral; Intra-Aortic Balloon Pumping; Methylprednisolone; Myocardial Contraction; Myocardial Infarction; Myocardium; Nitroglycerin; Oxygen Consumption; Shock, Cardiogenic; Vasoconstrictor Agents; Vasodilator Agents | 1979 |
Evaluation of the hemodynamic effects of hyaluronidase in patients with acute myocardial infarction.
Topics: Hemodynamics; Humans; Hyaluronoglucosaminidase; Myocardial Infarction | 1978 |
Early augmentation of R wave voltage after coronary artery occlusion: a useful index of myocardial injury.
Topics: Animals; Coronary Circulation; Coronary Vessels; Creatine Kinase; Dogs; Electrocardiography; Female; Humans; Hyaluronoglucosaminidase; Ligation; Male; Microspheres; Myocardial Infarction; Myocardium; Necrosis; Prognosis | 1979 |
[Effect of hyaluronidase on morphological changes in the myocardium in experimental myocardial infarct].
Topics: Animals; Drug Evaluation; Esterases; Glucosephosphate Dehydrogenase; Heart; Histocytochemistry; Hyaluronoglucosaminidase; Male; Myocardial Infarction; Myocardium; Rabbits; Succinate Dehydrogenase | 1979 |
Inhibition of Wydase by human serum.
Topics: Animals; Blood Physiological Phenomena; Cattle; Enzyme Inhibitors; Hyaluronoglucosaminidase; Male; Myocardial Infarction; Testis | 1979 |
[Study of the effect of hyaluronidase on the course of myocardial infarct].
Topics: Drug Evaluation; Follow-Up Studies; Humans; Hyaluronoglucosaminidase; Myocardial Infarction | 1978 |
Long-term preservation of ischemic myocardium in the dog by hyaluronidase.
Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Heart; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium | 1978 |
A method for demonstrating the efficacy of interventions designed to limit infarct size following coronary occlusion: beneficial effect of hyaluronidase.
Topics: Animals; Coronary Circulation; Creatine Kinase; Dogs; Female; Heart; Hyaluronoglucosaminidase; Male; Methods; Myocardial Infarction; Myocardium | 1978 |
Effects of pharmacological intervention on infarct size following induced myocardial infarction in rats.
Topics: Animals; Creatine Kinase; Hyaluronoglucosaminidase; Insulin; Isoproterenol; Male; Myocardial Infarction; Necrosis; Potassium; Prednisolone; Rats | 1978 |
From the NIH: Used early after attack, hyaluronidase protects heart muscle from blood-deprivation destruction.
Topics: Animals; Heart; Heart Failure; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Shock, Cardiogenic | 1979 |
[Some new aspects of the treatment of acute myocardial infarct].
Topics: Acute Disease; Angiography; Arrhythmias, Cardiac; Coronary Angiography; Electric Countershock; Fibrinolytic Agents; Glucagon; Heart Block; Humans; Hyaluronoglucosaminidase; Myocardial Contraction; Myocardial Infarction; Myocardium; Shock, Cardiogenic | 1977 |
The influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on salvage of ischemic myocardium in dogs.
Topics: Animals; Coronary Disease; Creatine Kinase; Dogs; Electrocardiography; Female; Hyaluronoglucosaminidase; Male; Myocardial Infarction; Myocardium; Necrosis; Time Factors | 1977 |
Use of hyaluronidase in myocardial infarction.
Topics: Electrocardiography; Humans; Hyaluronoglucosaminidase; Myocardial Infarction | 1977 |
[Electron-microscopic study of changes in the myocyte ultrastructure under the effect of hyaluronidase in experimental myocardial infarct].
Topics: Animals; Drug Evaluation; Hyaluronoglucosaminidase; Male; Microscopy, Electron; Myocardial Infarction; Myocardium; Rabbits | 1977 |
Failure of hyaluronidase to alter the early course of acute myocardial infarction in pigs.
Topics: Acute Disease; Animals; Blood Pressure; Cardiac Output; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Hyaluronoglucosaminidase; Infusions, Parenteral; Myocardial Contraction; Myocardial Infarction; Swine | 1976 |
Hyaluronidase-induced reductions in myocardial infarct size.
Topics: Animals; Creatine Kinase; Heart Ventricles; Hyaluronoglucosaminidase; Male; Myocardial Infarction; Myocardium; Rats; Time Factors | 1976 |
Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion.
Topics: Animals; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Female; Hyaluronoglucosaminidase; Male; Myocardial Infarction; Propranolol | 1976 |
The use of hyaluronidase and hydrocortisone in the reduction of myocardial infarct size following coronary occlusion. Experimental and clinical observations.
Topics: Acute Disease; Animals; Dogs; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Myocardial Infarction; Myocardium; Necrosis | 1976 |
Effects of hyaluronidase and hydrocortisone on myocardial necrosis after coronary occlusion.
Topics: Animals; Coronary Vessels; Dogs; Heart; Hyaluronoglucosaminidase; Hydrocortisone; Myocardial Infarction | 1976 |
[Some lysosome enzymes activity in the serum and urine of patients after myocardial infarction (author's transl)].
Topics: Cathepsins; Glucuronidase; Humans; Hyaluronoglucosaminidase; Lysosomes; Myocardial Infarction; Ribonucleases; Sulfatases | 1976 |
Myocardial infarction treated with two lymphagogues, calcium dobesilate (CLS 2210) and hyaluronidase: a coded, placebo-controlled animal study.
Topics: Animals; Benzenesulfonates; Calcium Dobesilate; Coronary Disease; Coronary Vessels; Creatine Kinase; Dogs; Electrocardiography; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium; Tetrazolium Salts; Tomography, X-Ray Computed | 1990 |
Accumulation of hyaluronan and tissue edema in experimental myocardial infarction.
Topics: Animals; Body Water; Edema; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1991 |
Active drainage of cardiac lymph in relation to reduction in size of myocardial infarction: an experimental study.
Topics: Animals; Coronary Circulation; Creatine Kinase; Dogs; Female; Heart; Hyaluronoglucosaminidase; Lymph; Male; Myocardial Infarction; Myocardium | 1990 |
Protective effects of sodium selenite on experimental myocardial infarction.
Topics: Animals; Female; Heart; Hemodynamics; Hyaluronoglucosaminidase; Myocardial Infarction; Rats; Rats, Inbred Strains; Selenium; Sodium Selenite; Solanaceous Alkaloids; Vasodilator Agents | 1989 |
Assessing efficacy of therapeutic intervention on myocardial infarction process by enzymatic prediction method.
Topics: Creatine Kinase; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Predictive Value of Tests; Propranolol | 1989 |
[Relation between limiting the size of myocardial infarct and heart function improvement].
Topics: Animals; Female; Heart; Hyaluronoglucosaminidase; Myocardial Infarction; Rats; Rats, Inbred Strains; Selenic Acid; Selenium; Selenium Compounds; Solanaceous Alkaloids | 1986 |
Delay of development of transmural irreversible ischaemic injury in canine myocardium.
Topics: Animals; Coronary Disease; Dogs; Female; Hyaluronoglucosaminidase; Male; Myocardial Infarction; Time Factors | 1987 |
The co-operative action of hyaluronidase and urokinase on the isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Drug Administration Schedule; Drug Therapy, Combination; Hyaluronoglucosaminidase; Injections, Intravenous; Isoproterenol; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Urokinase-Type Plasminogen Activator | 1986 |
Early disappearance of lymphatics draining ischemic myocardium in the dog.
Topics: Animals; Benzenesulfonates; Dogs; Female; Heart; Heparin; Hyaluronoglucosaminidase; Lymph; Lymphatic System; Lymphography; Male; Myocardial Infarction | 1987 |
Preferential uptake of intravenously administered hyaluronidase (Hyalosidase) by damaged rat myocardium.
Topics: Animals; Creatine Kinase; Female; Hyaluronoglucosaminidase; Injections, Intravenous; Myocardial Infarction; Myocardium; Rats; Tissue Distribution | 1985 |
Myocardial infarct size and mortality in diabetic patients.
Topics: Aspartate Aminotransferases; Creatine Kinase; Diabetes Complications; Diabetes Mellitus; Electrocardiography; Female; Humans; Hyaluronoglucosaminidase; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies | 1985 |
[Effect of hyaluronidase on the interrelations of the stromal elements of the myocardium in the healing of experimental myocardial infarct].
Topics: Animals; Drug Evaluation, Preclinical; Glycosaminoglycans; Heart; Histocytochemistry; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium; Rabbits; Wound Healing | 1985 |
Modification of myocardial infarction size after coronary occlusion.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Digitalis Glycosides; Dogs; Electric Countershock; Heart Rate; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium; Oxygen Consumption; Time Factors | 1973 |
Investigations on protection of the ischemic myocardium.
Topics: Animals; Assisted Circulation; Creatine Kinase; Digitalis Glycosides; Dogs; Electrocardiography; Glucose; Heart; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Insulin; Isoproterenol; Myocardial Infarction; Myocardium; Oxygen Consumption; Perfusion; Potassium; Propranolol | 1973 |
Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Coronary Disease; Creatine Kinase; Dogs; Electrocardiography; Glycogen; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium; Necrosis; Spectrophotometry; Time Factors | 1972 |